{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:10:49Z","timestamp":1793826649936,"version":"4.6.1"},"reference-count":200,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The gut microbiota plays a pivotal role in the pathogenesis and progression of various liver diseases, including viral hepatitis, alcoholic fatty liver disease, metabolic dysfunction-associated steatotic liver disease, drug-induced hepatitis, liver cirrhosis, hepatocellular carcinoma, and other hepatic disorders. Research indicates that dysbiosis of the gut microbiota can disrupt the integrity of the intestinal barrier and interfere with the immune functions of the gut-liver axis, thereby mediating the progression of liver diseases. Analysis of microbial composition and metabolites in fecal samples can assess the diversity of gut microbiota and the abundance of specific microbial populations, providing auxiliary diagnostic information for liver diseases. Furthermore, interventions such as fecal microbiota transplantation, probiotics, prebiotics, bacteriophages, and necessary antibiotic treatments offer multiple approaches to modulate the gut microbiota, presenting promising new strategies for the prevention and treatment of liver diseases. This review summarizes the latest research advances on the role of gut microbiota in liver diseases, offering novel theoretical foundations and practical directions for the diagnosis and treatment of hepatic disorders.<\/jats:p>","DOI":"10.3389\/fmed.2025.1615839","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:37:12Z","timestamp":1749015432000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Gut microbiota in liver diseases: initiation, development and therapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Jian-Xiu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-gang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Pei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-hai","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"BSR20182057","DOI":"10.1042\/BSR20182057","article-title":"Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma","volume":"39","author":"Wang","year":"2019","journal-title":"Biosci Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden ofliver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.hbpd.2024.12.004","article-title":"Diagnostic value and immune infiltration characterization of WTAP as a critical m6A regulator in liver transplantation","volume":"24","author":"Li","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/1389450123666220309101345","article-title":"Bugs as drugs: understanding the linkage between gut microbiota and cancer treatment","volume":"23","author":"Rana","year":"2022","journal-title":"Curr Drug Targets"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1192506","DOI":"10.3389\/fimmu.2023.1192506","article-title":"Immunotherapy of hepatocellular carcinoma: recent progress and new strategy","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"G84","DOI":"10.1152\/ajpgi.00118.2019","article-title":"Role of gut microbiota in liver disease","volume":"318","author":"Albhaisi","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"105101","DOI":"10.1016\/j.ebiom.2024.105101","article-title":"Virological response to nucleos(t)ide analogues treatment in chronic hepatitis B patients is associated with Bacteroides-dominant gut microbiome","volume":"103","author":"Zhang","year":"2024","journal-title":"EBioMedicine"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41564-022-01273-y","article-title":"Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis","volume":"8","author":"Ali","year":"2023","journal-title":"Nat Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/jvh.13595","article-title":"The role of gut microbiota in hepatitis B disease progression and treatment","volume":"29","author":"Chen","year":"2022","journal-title":"J Viral Hepat"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00535-024-02134-7","article-title":"Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation","volume":"59","author":"Hao","year":"2024","journal-title":"J Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1155\/agm3\/7351229","article-title":"Gut\u2013Oral microbial Dysbiosis: a correlated ecosystem","volume-title":"Advanced Gut and Microbiome Research","author":"Siddiqui","year":"2025"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"112747","DOI":"10.1016\/j.intimp.2024.112747","article-title":"Role of gut\/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis","volume":"139","author":"Xie","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.3350\/cmh.2024.0811","article-title":"Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Saeed","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2240031","DOI":"10.1080\/19490976.2023.2240031","article-title":"Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions","volume":"15","author":"Rajapakse","year":"2023","journal-title":"Gut Microbes"},{"key":"ref16","article-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030","year":"2022"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1119875","DOI":"10.3389\/fcimb.2023.1119875","article-title":"Alterations of the gut microbiota associated with the occurrence and progression of viral hepatitis","volume":"13","author":"Yang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref18","article-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","year":"2024"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13099-023-00549-w","article-title":"Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease","volume":"15","author":"Lin","year":"2023","journal-title":"Gut Pathog"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12866-024-03457-4","article-title":"Role of tenofovir dipivoxil in gut microbiota recovery from HBV-infection induced dysbiosis","volume":"24","author":"Long","year":"2024","journal-title":"BMC Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jvh.13216","article-title":"Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma","volume":"27","author":"Zeng","year":"2020","journal-title":"J Viral Hepat"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0023924","DOI":"10.1128\/spectrum.00239-24","article-title":"Altered gut microbiota is associated with the formation of occult hepatitis B virus infection","volume":"12","author":"Liu","year":"2024","journal-title":"Microbiol Spectr"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1152987","DOI":"10.3389\/fcimb.2023.1152987","article-title":"Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response","volume":"13","author":"Yan","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1021\/acsinfecdis.0c00432","article-title":"Alterations of the treatment-naive gut microbiome in newly diagnosed hepatitis C virus infection","volume":"7","author":"Sultan","year":"2021","journal-title":"ACS Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/cid\/ciy205","article-title":"Gut Dysbiosis associated with hepatitis C virus infection","volume":"67","author":"Inoue","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13099-022-00501-4","article-title":"Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load","volume":"14","author":"Ashour","year":"2022","journal-title":"Gut Pathog"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jmv.27356","article-title":"Gut microbiota dysbiosis associated with plasma levels of interferon-\u03b3 and viral load in patients with acute hepatitis E infection","volume":"94","author":"Wu","year":"2022","journal-title":"J Med Virol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/jvh.13344","article-title":"Altered faecal microbiota on the expression of Th cells responses in the exacerbation of patients with hepatitis E infection","volume":"27","author":"Wu","year":"2020","journal-title":"J Viral Hepat"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/v13102101","article-title":"Prolonged gut Dysbiosis and fecal excretion of hepatitis a virus in patients infected with human immunodeficiency virus","volume":"13","author":"Ishizaka","year":"2021","journal-title":"Viruses"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.20524\/aog.2023.0776","article-title":"Intestinal dysbiosis and probiotic use: its place in hepatic encephalopathy in cirrhosis","volume":"36","author":"Daz\u0131ro\u011flu ME\u00c7","year":"2023","journal-title":"Ann Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3390\/microorganisms11102437","article-title":"Ethanol-producing Enterocloster bolteae is enriched in chronic hepatitis B-associated gut Dysbiosis: a case-control Culturomics study","volume":"11","author":"Magdy Wasfy","year":"2023","journal-title":"Microorganisms"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1232180","DOI":"10.3389\/fmicb.2023.1232180","article-title":"Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora","volume":"14","author":"Long","year":"2023","journal-title":"Front Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jcmgh.2023.12.003","article-title":"Antagonism between gut Ruminococcus gnavus and Akkermansia muciniphila modulates the progression of chronic hepatitis B","volume":"17","author":"Chua","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1921925","article-title":"Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure","volume":"13","author":"Wang","year":"2021","journal-title":"Gut Microbes"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"573923","DOI":"10.3389\/fcimb.2021.573923","article-title":"Impact of the gut microbiome on the progression of hepatitis B virus related acute-on-chronic liver failure","volume":"11","author":"Yao","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2155018","DOI":"10.1080\/19490976.2022.2155018","article-title":"Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response","volume":"15","author":"Shen","year":"2023","journal-title":"Gut Microbes"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.3748\/wjg.v30.i31.3668","article-title":"Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension","volume":"30","author":"Zhao","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41598-022-09534-w","article-title":"Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents","volume":"12","author":"Hsu","year":"2022","journal-title":"Sci Rep"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","article-title":"Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma","volume":"68","author":"Ren","year":"2019","journal-title":"Gut"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"113304","DOI":"10.1016\/j.intimp.2024.113304","article-title":"Inhibition of hepatitis B virus through PPAR-JAK\/STAT pathway modulation by electroacupuncture and tenofovir disoproxil fumarate combination therapy","volume":"143","author":"Yang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.3748\/wjg.v27.i43.7446","article-title":"Overview of the microbiota in the gut-liver axis in viral B and C hepatitis","volume":"27","author":"Neag","year":"2021","journal-title":"World J Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14218\/JCTH.2020.00161","article-title":"Gut microbiota Dysbiosis strengthens Kupffer cell-mediated hepatitis B virus persistence through inducing Endotoxemia in mice","volume":"10","author":"Zhou","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"199129","DOI":"10.1016\/j.virusres.2023.199129","article-title":"Peyer's patch-involved gut microbiota facilitates anti-HBV immunity in mice","volume":"331","author":"Li","year":"2023","journal-title":"Virus Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/liv.15041","article-title":"Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection","volume":"42","author":"Inoue","year":"2022","journal-title":"Liver Int"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13568-023-01539-6","article-title":"Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"AMB Express"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2201159","DOI":"10.1080\/19490976.2023.2201159","article-title":"A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma","volume":"15","author":"Yang","year":"2023","journal-title":"Gut Microbes"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1458754","DOI":"10.3389\/fmicb.2024.1458754","article-title":"Effect of intestinal microbiota transplantation on chronic hepatitis B virus infection associated liver disease","volume":"15","author":"Deng","year":"2024","journal-title":"Front Microbiol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/hep.29008","article-title":"Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy","volume":"65","author":"Ren","year":"2017","journal-title":"Hepatology"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s10620-020-06246-x","article-title":"Fecal microbiota transplantation in hepatitis B e antigen-positive chronic hepatitis B patients: a pilot study","volume":"66","author":"Chauhan","year":"2021","journal-title":"Dig Dis Sci"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","article-title":"Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT","volume":"174","author":"Suez","year":"2018","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3760\/cma.j.cn501113-20221220-00605","article-title":"Guideline for the prevention and treatment of hepatitis C (2022 version)","volume":"30","year":"2022","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"14413","DOI":"10.1038\/s41598-023-41664-7","article-title":"Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection","volume":"13","author":"Chuaypen","year":"2023","journal-title":"Sci Rep"},{"key":"ref53","first-page":"196","article-title":"Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study","volume":"46","author":"Pinchera","year":"2023","journal-title":"New Microbiol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejim.2019.06.005","article-title":"Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients","volume":"67","author":"P\u00e9rez-Matute","year":"2019","journal-title":"Eur J Intern Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/apt.15004","article-title":"Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis","volume":"48","author":"Ponziani","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hep.31700","article-title":"Eradication of chronic HCV infection: improvement of dysbiosis only in patients without liver cirrhosis","volume":"74","author":"Wellh\u00f6ner","year":"2021","journal-title":"Hepatology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jfma.2022.08.022","article-title":"Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C","volume":"122","author":"Huang","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.12938\/bmfh.2015-024","article-title":"Safety and long-term effect of the probiotic FK-23 in patients with hepatitis C virus infection","volume":"35","author":"Oo","year":"2016","journal-title":"Biosci Microbiota Food Health"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5897\/AJMR2018.9028","article-title":"Lactobacillus acidophilus and Bifidobacteria spp having antibacterial and antiviral effects on chronic HCV infection","volume":"13","author":"Nanis","year":"2019","journal-title":"Afr J Microbiol Res"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.coviro.2019.05.007","article-title":"Virome and bacteriome: two sides of the same coin","volume":"37","author":"Stern","year":"2019","journal-title":"Curr Opin Virol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"133014","DOI":"10.1016\/j.ijbiomac.2024.133014","article-title":"Haematococcus pluvialis polysaccharides improve microbiota-driven gut epithelial and vascular barrier and prevent alcoholic steatohepatitis development","volume":"274","author":"Liu","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.2147\/IJGM.S420195","article-title":"Roles of gut microbiota in alcoholic liver disease","volume":"16","author":"Zhang","year":"2023","journal-title":"Int J Gen Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/pharmaceutics15020636","article-title":"Exosome-based delivery of super-repressor I\u03baB\u03b1 alleviates alcohol-associated liver injury in mice","volume":"15","author":"Kim","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12072-023-10518-9","article-title":"Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease","volume":"18","author":"Ganesan","year":"2024","journal-title":"Hepatol Int"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"128394","DOI":"10.1016\/j.ijbiomac.2023.128394","article-title":"The gut-liver axis perspective: exploring the protective potential of polysaccharides from Cistanche deserticola against alcoholic liver disease","volume":"256","author":"Wang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1021\/acs.jproteome.3c00093","article-title":"Metabolomics reveals gut microbiota contribute to PPAR\u03b1 deficiency-induced alcoholic liver injury","volume":"22","author":"Zhang","year":"2023","journal-title":"J Proteome Res"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3390\/foods13152431","article-title":"Pueraria lobata-Prunus mume Complex alleviates alcoholic liver disease by regulating lipid metabolism and inhibiting inflammation: a transcriptome and gut microbiota analysis","volume":"13","author":"Gao","year":"2024","journal-title":"Food Secur"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"175096","DOI":"10.1016\/j.ejphar.2022.175096","article-title":"Ameliorative effects of chlorogenic acid on alcoholic liver injury in mice via gut microbiota informatics","volume":"928","author":"Zhu","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1163\/18762891-bja00022","article-title":"Lacticaseibacillus rhamnosus LRa05 alleviated liver injury in mice with alcoholic fatty liver disease by improving intestinal permeability and balancing gut microbiota","volume":"15","author":"Gu","year":"2024","journal-title":"Benef Microbes"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"649060","DOI":"10.3389\/fcimb.2021.649060","article-title":"Streptococcus, the predominant bacterium to predict the severity of liver injury in alcoholic liver disease","volume":"11","author":"Zhong","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"16122","DOI":"10.1038\/s41598-024-60768-2","article-title":"Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease","volume":"14","author":"Park","year":"2024","journal-title":"Sci Rep"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/liv.14383","article-title":"Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease","volume":"40","author":"Addolorato","year":"2020","journal-title":"Liver Int"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jare.2024.07.002","article-title":"The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD","volume":"72","author":"Cheng","year":"2024","journal-title":"J Adv Res"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-med-060513-093205","article-title":"The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases","volume":"66","author":"Brown","year":"2015","journal-title":"Annu Rev Med"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"9420","DOI":"10.3390\/ijms25179420","article-title":"A butyrate-yielding dietary supplement prevents acute alcoholic liver injury by modulating Nrf2-mediated hepatic oxidative stress and gut microbiota","volume":"25","author":"Xu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"140460","DOI":"10.1016\/j.foodchem.2024.140460","article-title":"Hepatoprotective potential of four fruit extracts rich in different structural flavonoids against alcohol-induced liver injury via gut microbiota-liver axis","volume":"460","author":"Chen","year":"2024","journal-title":"Food Chem"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.chom.2024.06.008","article-title":"Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification","volume":"32","author":"Shen","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"114489","DOI":"10.1016\/j.foodres.2024.114489","article-title":"Solanum nigrum L. berries extract ameliorated the alcoholic liver injury by regulating gut microbiota, lipid metabolism, inflammation, and oxidative stress","volume":"188","author":"Wang","year":"2024","journal-title":"Food Res Int"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"23819","DOI":"10.1021\/acs.jafc.4c04131","article-title":"Trilobatin, a novel naturally occurring food additive, ameliorates alcoholic liver disease in mice: involvement of microbiota-gut-liver Axis and yap\/Nrf2 signaling pathway","volume":"72","author":"Yi","year":"2024","journal-title":"J Agric Food Chem"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.3390\/nu16132139","article-title":"Lactobacillus rhamnosus NKU FL1-8 isolated from infant feces ameliorates the alcoholic liver damage by regulating the gut microbiota and intestinal barrier in C57BL\/6J mice","volume":"16","author":"Liu","year":"2024","journal-title":"Nutrients"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.14309\/ajg.0000000000002283","article-title":"The beneficial effects of Lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis","volume":"118","author":"Vatsalya","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1039\/d4fo02592j","article-title":"The alleviative effects of viable and inactive Lactobacillus paracasei CCFM1120 against alcoholic liver disease via modulation of gut microbiota and the Nrf2\/HO-1 and TLR4\/MyD88\/NF-\u03baB pathways","volume":"15","author":"Niu","year":"2024","journal-title":"Food Funct"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"869250","DOI":"10.3389\/fmicb.2022.869250","article-title":"Probiotic lactobacilli ameliorate alcohol-induced hepatic damage via gut microbial alteration","volume":"13","author":"Kim","year":"2022","journal-title":"Front Microbiol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","article-title":"Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial","volume":"16","author":"Sharma","year":"2022","journal-title":"Hepatol Int"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"102478","DOI":"10.1016\/j.clinre.2024.102478","article-title":"Therapeutic effects of fecal microbial transplantation on alcoholic liver injury in rat models","volume":"48","author":"Zhang","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1039\/d4fo01070a","article-title":"Musculus senhousei peptides alleviated alcoholic liver injury via the gut-liver axis","volume":"15","author":"Xiao","year":"2024","journal-title":"Food Funct"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"10067","DOI":"10.1039\/d4fo02256d","article-title":"The dose-dependent mechanism behind the protective effect of lentinan against acute alcoholic liver injury via proliferating intestinal probiotics","volume":"15","author":"Zhao","year":"2024","journal-title":"Food Funct"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J Lipid Res"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"e945198","DOI":"10.12659\/MSM.945198","article-title":"Why MASLD lags behind MAFLD: a critical analysis of diagnostic criteria evolution in metabolic dysfunction-associated liver diseases","volume":"30","author":"Alboraie","year":"2024","journal-title":"Med Sci Monit"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"e0299946","DOI":"10.1371\/journal.pone.0299946","article-title":"Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis","volume":"19","author":"Cai","year":"2024","journal-title":"PLoS One"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12938\/bmfh.2020-046","article-title":"Correlation of gut Firmicutes\/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease","volume":"40","author":"Jasirwan","year":"2021","journal-title":"Biosci Microbiota Food Health"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/nu12030820","article-title":"Gut microbiota Dysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: a cross-sectional study in Taiwan","volume":"12","author":"Tsai","year":"2020","journal-title":"Nutrients"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1002\/ctm2.634","article-title":"Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease","volume":"11","author":"Yu","year":"2021","journal-title":"Clin Transl Med"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ijbiomac.2021.05.066","article-title":"Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation","volume":"183","author":"Gao","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12887-024-05268-y","article-title":"Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?","volume":"24","author":"Amrousy","year":"2024","journal-title":"BMC Pediatr"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"106348","DOI":"10.1016\/j.phrs.2022.106348","article-title":"Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury","volume":"182","author":"Rodriguez-Diaz","year":"2022","journal-title":"Pharmacol Res"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.3390\/nu14245323","article-title":"Gut microbiota in non-alcoholic fatty liver disease patients with inflammatory bowel diseases: a complex interplay","volume":"14","author":"Abenavoli","year":"2022","journal-title":"Nutrients"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/hep.32705","article-title":"Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression","volume":"77","author":"Ju\u00e1rez-Fern\u00e1ndez","year":"2023","journal-title":"Hepatology"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat Commun"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00535-023-02075-7","article-title":"Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism","volume":"59","author":"Cornejo-Pareja","year":"2024","journal-title":"J Gastroenterol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"eabk0855","DOI":"10.1126\/scitranslmed.abk0855","article-title":"Risk assessment with gut microbiome and metabolite markers in NAFLD development","volume":"14","author":"Leung","year":"2022","journal-title":"Sci Transl Med"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e03263-19","DOI":"10.1128\/mBio.03263-19","article-title":"Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease","volume":"11","author":"Fei","year":"2020","journal-title":"mBio"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"113173","DOI":"10.1016\/j.intimp.2024.113173","article-title":"Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance","volume":"142","author":"Nian","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1017\/S0007114524000631","article-title":"Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease","volume":"131","author":"Ma","year":"2024","journal-title":"Br J Nutr"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1085041","DOI":"10.3389\/fendo.2023.1085041","article-title":"The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases","volume":"14","author":"Zhen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1371574","DOI":"10.3389\/fphar.2024.1371574","article-title":"Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"15","author":"Mao","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/nu15051175","article-title":"Severity of liver fibrosis is associated with the Japanese diet pattern and skeletal muscle mass in patients with nonalcoholic fatty liver disease","volume":"15","author":"Matsumoto","year":"2023","journal-title":"Nutrients"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.cmet.2024.04.015","article-title":"A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR\u03b1 and PCK1","volume":"36","author":"Gallage","year":"2024","journal-title":"Cell Metab"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4014\/jmb.2310.10026","article-title":"Hepatoprotective effect of Lactiplantibacillus plantarum DSR330 in mice with high fat diet-induced nonalcoholic fatty liver disease","volume":"34","author":"Lee","year":"2024","journal-title":"J Microbiol Biotechnol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"2304159","DOI":"10.1080\/19490976.2024.2304159","article-title":"Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1038\/s41598-019-42059-3","article-title":"Randomized, double-blind, placebo-controlled study of a multispecies probiotic mixture in nonalcoholic fatty liver disease","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci Rep"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1362694","DOI":"10.3389\/fnut.2024.1362694","article-title":"Probiotic supplementation for 24\u202fweeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial","volume":"11","author":"Silva-Sperb","year":"2024","journal-title":"Front Nutr"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1017\/S0007114517000204","article-title":"Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial","volume":"117","author":"Mofidi","year":"2017","journal-title":"Br J Nutr"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1039\/c9fo02905b","article-title":"Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways","volume":"11","author":"Wang","year":"2020","journal-title":"Food Funct"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"e2400754","DOI":"10.1002\/mnfr.202400754","article-title":"Postbiotics as Antiinflammatory and immune-modulating bioactive compounds in metabolic dysfunction-associated Steatotic liver disease","volume":"68","author":"Yilmaz","year":"2024","journal-title":"Mol Nutr Food Res"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/gutjnl-2023-330584","article-title":"Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers","volume":"73","author":"Trebicka","year":"2024","journal-title":"Gut"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3760\/cma.j.cn501113-20220830-00440","article-title":"Comparative analysis of intestinal microbiota distribution characteristics based on metagenomics in patients with hepatitis B cirrhosis with or without ascites","volume":"31","author":"Luan","year":"2023","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1097\/MEG.0000000000001978","article-title":"The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma","volume":"33","author":"Tang","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/microorganisms12030463","article-title":"Gut microbiota and biomarkers of intestinal barrier damage in cirrhosis","volume":"12","author":"Efremova","year":"2024","journal-title":"Microorganisms"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","article-title":"Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1438897","DOI":"10.3389\/fnut.2024.1438897","article-title":"Akkermansia muciniphila is associated with normal muscle mass and Eggerthella is related with sarcopenia in cirrhosis","volume":"11","author":"Efremova","year":"2024","journal-title":"Front Nutr"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"689","DOI":"10.14218\/JCTH.2024.00090","article-title":"Gut microbiota and cytokine profile in cirrhosis","volume":"12","author":"Efremova","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/apt.14397","article-title":"Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease","volume":"47","author":"Woodhouse","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"e32335","DOI":"10.1097\/MD.0000000000032335","article-title":"Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"101","author":"Huang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.3390\/ijms22136921","article-title":"Intestinal permeability is a mechanical rheostat in the pathogenesis of liver cirrhosis","volume":"22","author":"Nishimura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MOG.0000000000000971","article-title":"Small intestinal bacterial overgrowth: current update","volume":"39","author":"Zafar","year":"2023","journal-title":"Curr Opin Gastroenterol"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"964","DOI":"10.5152\/tjg.2019.18551","article-title":"Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?","volume":"30","author":"Maslennikov","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1371429","DOI":"10.3389\/fcimb.2024.1371429","article-title":"Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients","volume":"14","author":"Midori","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3748\/wjg.v30.i11.1556","article-title":"Effects of Lactobacillus paracasei N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis","volume":"30","author":"Hu","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"176874","DOI":"10.1016\/j.ejphar.2024.176874","article-title":"Efficacy of probiotics on improvement of health outcomes in cirrhotic liver disease patients: a systematic review and meta-analysis of randomised controlled trials","volume":"981","author":"Leitner","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40168-024-01924-8","article-title":"Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis","volume":"12","author":"Kang","year":"2024","journal-title":"Microbiome"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"102361","DOI":"10.1016\/j.clinre.2024.102361","article-title":"Effect of probiotics on portal hypertension (PH) with cirrhosis: a systematic review and meta-analysis","volume":"48","author":"Chang","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"e0443","DOI":"10.1097\/HC9.0000000000000443","article-title":"Home exercise, branched-chain amino acids, and probiotics improve frailty in cirrhosis: a randomized clinical trial","volume":"8","author":"Rom\u00e1n","year":"2024","journal-title":"Hepatol Commun"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/hep4.1950","article-title":"Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient","volume":"6","author":"Bloom","year":"2022","journal-title":"Hepatol Commun"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/antibiotics11070838","article-title":"Fecal microbiota transplantation in decompensated cirrhosis: a systematic review on safety and efficacy","volume":"11","author":"Hong","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.22038\/IJBMS.2024.74280.16142","article-title":"Therapeutic effect of fecal microbiota transplantation on rats with liver cirrhosis and its influence on gut microbiota","volume":"27","author":"Chen","year":"2024","journal-title":"Iran J Basic Med Sci"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/gutjnl-2023-330699","article-title":"Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis","volume":"73","author":"Liu","year":"2024","journal-title":"Gut"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC - mechanisms, diagnosis and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J Hepatol"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/nu16050600","article-title":"In vitro lactic acid Bacteria anti-hepatitis B virus (HBV) effect and modulation of the intestinal microbiota in fecal cultures from HBV-associated hepatocellular carcinoma patients","volume":"16","author":"Yang","year":"2024","journal-title":"Nutrients"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00253-023-12845-1","article-title":"Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma","volume":"108","author":"Jinato","year":"2024","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1111\/cas.15983","article-title":"Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma","volume":"114","author":"Zheng","year":"2023","journal-title":"Cancer Sci"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"2283160","DOI":"10.1080\/07853890.2023.2283160","article-title":"Specific gut microbiome signature predicts hepatitis B virus-related hepatocellular carcinoma patients with microvascular invasion","volume":"55","author":"Peng","year":"2023","journal-title":"Ann Med"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"2297846","DOI":"10.1080\/19490976.2023.2297846","article-title":"B. thetaiotaomicron-derived acetic acid modulate immune microenvironment and tumor growth in hepatocellular carcinoma","volume":"16","author":"Ma","year":"2024","journal-title":"Gut Microbes"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/liv.15466","article-title":"Association of gut microbiome and primary liver cancer: a two-sample Mendelian randomization and case-control study","volume":"43","author":"Ma","year":"2023","journal-title":"Liver Int"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1002\/cam4.3045","article-title":"Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma","volume":"9","author":"Zheng","year":"2020","journal-title":"Cancer Med"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3748\/wjg.v26.i16.1861","article-title":"Macrophages in metabolic associated fatty liver disease","volume":"26","author":"Alharthi","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"11504","DOI":"10.1074\/jbc.M115.709048","article-title":"Toll-like receptor 4 on macrophage promotes the development of steatohepatitis-related hepatocellular carcinoma in mice","volume":"291","author":"Miura","year":"2016","journal-title":"J Biol Chem"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41564-024-01890-9","article-title":"Gut-liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice","volume":"10","author":"Wang","year":"2025","journal-title":"Nat Microbiol"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.xcrm.2024.101900","article-title":"Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma","volume":"6","author":"Wu","year":"2025","journal-title":"Cell Rep Med"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.32449","article-title":"Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC","volume":"77","author":"Hu","year":"2023","journal-title":"Hepatology"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","article-title":"Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment","volume":"13","author":"Schneider","year":"2022","journal-title":"Nat Commun"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"fuad046","DOI":"10.1093\/femsre\/fuad046","article-title":"Exploring probiotic effector molecules and their mode of action in gut-immune interactions","volume":"47","author":"Lee","year":"2023","journal-title":"FEMS Microbiol Rev"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"2190304","DOI":"10.1080\/19490976.2023.2190304","article-title":"Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17\/Treg balance and gut microbiota structure","volume":"15","author":"Guo","year":"2023","journal-title":"Gut Microbes"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cmet.2023.09.009","article-title":"High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate","volume":"35","author":"Zhou","year":"2023","journal-title":"Cell Metab"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.jcmgh.2024.05.003","article-title":"Interplay between drug-induced liver injury and gut microbiota: a comprehensive overview","volume":"18","author":"Li","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update","volume":"94","author":"Garcia-Cortes","year":"2020","journal-title":"Arch Toxicol"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"e0159621","DOI":"10.1128\/spectrum.01596-21","article-title":"Akkermansia muciniphila ameliorates acetaminophen-induced liver injury by regulating gut microbial composition and metabolism","volume":"10","author":"Xia","year":"2022","journal-title":"Microbiol Spectr"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3390\/nu14132636","article-title":"Broussonetia papyrifera polysaccharide alleviated acetaminophen-induced liver injury by regulating the intestinal Flora","volume":"14","author":"Xu","year":"2022","journal-title":"Nutrients"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.3390\/ijms25136863","article-title":"Idiosyncratic drug-induced liver injury and amoxicillin-Clavulanate: spotlight on gut microbiota, fecal metabolome and bile acid profile in patients","volume":"25","author":"Rom\u00e1n-Sag\u00fcillo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"9845","DOI":"10.1007\/s00210-024-03242-0","article-title":"The potential liver injury induced by metronidazole-provoked disturbance of gut microbiota: modulatory effect of turmeric supplementation","volume":"397","author":"Ali","year":"2024","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"e0144854","DOI":"10.1371\/journal.pone.0144854","article-title":"Antibiotic treatment affects intestinal permeability and gut microbial composition in Wistar rats dependent on antibiotic class","volume":"10","author":"Tulstrup","year":"2015","journal-title":"PLoS One"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"1432049","DOI":"10.3389\/fmicb.2024.1432049","article-title":"Gut microbiota causally affects drug-induced liver injury via plasma metabolites: a Mendelian randomization study","volume":"15","author":"Fu","year":"2024","journal-title":"Front Microbiol"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.2147\/DDDT.S381667","article-title":"Integrated microbiome and metabolome analysis reveals correlations between gut microbiota components and metabolic profiles in mice with methotrexate-induced Hepatoxicity","volume":"16","author":"Wang","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"119293","DOI":"10.1016\/j.jep.2024.119293","article-title":"Pharmacodynamic material basis of licorice and mechanisms of modulating bile acid metabolism and gut microbiota in cisplatin-induced liver injury based on LC-MS and network pharmacology analysis","volume":"340","author":"Li","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ajpath.2019.09.009","article-title":"Intestinal epithelial chemokine (C-C motif) ligand 7 overexpression enhances acetaminophen-induced hepatotoxicity in mice","volume":"190","author":"Niu","year":"2020","journal-title":"Am J Pathol"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/cimb46020078","article-title":"Gut-liver Axis as a therapeutic target for drug-induced liver injury","volume":"46","author":"Tao","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"598170","DOI":"10.3389\/fphar.2020.598170","article-title":"Gut microbiota participates in Antithyroid drug induced liver injury through the lipopolysaccharide related signaling pathway","volume":"11","author":"Sun","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/liv.15512","article-title":"Ampicillin exacerbates acetaminophen-induced acute liver injury by inducing intestinal microbiota imbalance and butyrate reduction","volume":"43","author":"Li","year":"2023","journal-title":"Liver Int"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chom.2023.04.002","article-title":"Liberation of daidzein by gut microbial \u03b2-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice","volume":"31","author":"Zeng","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"113591","DOI":"10.1016\/j.celrep.2023.113591","article-title":"Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury","volume":"43","author":"Yang","year":"2024","journal-title":"Cell Rep"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.chom.2023.11.006","article-title":"Oral magnesium prevents acetaminophen-induced acute liver injury by modulating microbial metabolism","volume":"32","author":"Li","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"3259238","DOI":"10.1155\/2021\/3259238","article-title":"Oridonin alters hepatic urea cycle via gut microbiota and protects against acetaminophen-induced liver injury","volume":"2021","author":"Hong","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"107275","DOI":"10.1016\/j.phrs.2024.107275","article-title":"Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis","volume":"206","author":"Hu","year":"2024","journal-title":"Pharmacol Res"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.clnesp.2024.07.1024","article-title":"Probiotics may be useful for drug-induced liver dysfunction in patients with depression - a secondary analysis of a randomized clinical trial","volume":"63","author":"Gawlik-Kotelnicka","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1495170","DOI":"10.3389\/fmicb.2024.1495170","article-title":"Research on gut microbiota characteristics of PBC patients at different ALBI grades based on machine learning","volume":"15","author":"Shi","year":"2024","journal-title":"Front Microbiol"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"100504","DOI":"10.1016\/j.medj.2024.08.003","article-title":"Gut microbiome pattern impacts treatment response in primary biliary cholangitis","volume":"6","author":"Liu","year":"2025","journal-title":"Med"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/ibd\/izad288","article-title":"Altered bile acid and pouch microbiota composition in patients with chronic Pouchitis","volume":"30","author":"Santiago","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/diseases7040058","article-title":"Role of gut Dysbiosis in liver diseases: what have we learned So far?","volume":"7","author":"Fukui","year":"2019","journal-title":"Diseases"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"1348027","DOI":"10.3389\/fmicb.2024.1348027","article-title":"Association between gut microbiota and autoimmune cholestatic liver disease, a Mendelian randomization study","volume":"15","author":"Cui","year":"2024","journal-title":"Front Microbiol"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"1337223","DOI":"10.3389\/fcimb.2024.1337223","article-title":"The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review","volume":"14","author":"Sun","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"21025","DOI":"10.1038\/s41598-024-71740-5","article-title":"Multi-omics study unravels gut microbiota and metabolites alteration in patients with Wilson's disease","volume":"14","author":"Cai","year":"2024","journal-title":"Sci Rep"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.13381\/j.cnki.cjm.202212013","article-title":"Relationship between changes of intestinal flora and HBV-DNA level in patients with hepatitis B cirrhosis","volume":"34","author":"Cao","year":"2022","journal-title":"Chin J Microecol"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"1785251","DOI":"10.1080\/19490976.2020.1785251","article-title":"Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients","volume":"12","author":"Lang","year":"2020","journal-title":"Gut Microbes"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"100872","DOI":"10.1016\/j.jhepr.2023.100872","article-title":"24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPAR\u03b3","volume":"5","author":"Grander","year":"2023","journal-title":"JHEP Rep"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"2367342","DOI":"10.1080\/19490976.2024.2367342","article-title":"MUP1 mediates urolithin a alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis","volume":"16","author":"Zhang","year":"2024","journal-title":"Gut Microbes"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13020-024-00912-2","article-title":"Golden bile powder prevents drunkenness and alcohol-induced liver injury in mice via the gut microbiota and metabolic modulation","volume":"19","author":"Wang","year":"2024","journal-title":"Chin Med"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"e2405781","DOI":"10.1002\/advs.202405781","article-title":"Postbiotics from Lactobacillus johnsonii activates gut innate immunity to mitigate alcohol-associated liver disease","volume":"12","author":"Yin","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"e70099","DOI":"10.1002\/ctm2.70099","article-title":"NLRP3 activation maintains intestinal epithelial barrier and reduces liver injury in alcoholic liver disease mice","volume":"14","author":"Li","year":"2024","journal-title":"Clin Transl Med"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"874878","DOI":"10.3389\/fimmu.2022.874878","article-title":"Modulation of gut microbiota by magnesium isoglycyrrhizinate mediates enhancement of intestinal barrier function and amelioration of methotrexate-induced liver injury","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1615839\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:37:17Z","timestamp":1749015437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1615839\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":200,"alternative-id":["10.3389\/fmed.2025.1615839"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1615839","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"article-number":"1615839"}}